NCT03979937

Brief Summary

Development and validation of a simple diagnostic tool predictive of the aseptic character of joint effusion in the primary care setting.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
328

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 6, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 10, 2019

Completed
8 months until next milestone

Study Start

First participant enrolled

February 15, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
Last Updated

March 9, 2022

Status Verified

March 1, 2022

Enrollment Period

2 years

First QC Date

June 6, 2019

Last Update Submit

March 8, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Presence of a septic arthritis

    Presence of more than 2000 cells/mL and bacterial growth in the articular fluid.

    10 days after the arthrocentesis.

Interventions

Arthrocentesis to determine the nature of the effusion (septic or aseptic).

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All adult patients presenting with at least one clinical joint effusion accessible to arthrocentesis, interesting a native non operated joint, without any general antibiotic therapy in the previous 15 days.

You may qualify if:

  • Adult patient (age ≥ 18 years)
  • Hospitalized in the conventional hospitalization unit or day hospitalization unit or received in consultation within the Rheumatology or Infectious Diseases units at the Le Mans General Hospital
  • presenting at least one joint effusion at clinical examination
  • Interesting a native, nonoperated joint, accessible to a puncture based on clinical markers, determined by palpatory anatomy
  • Affiliated to social security
  • No opposition expressed after written information

You may not qualify if:

  • General antibiotic therapy in progress or completed less than 15 days before
  • Failure to perform the arthrocentesis
  • Person subject to a legal protection measure, not allowing his compliance with the study
  • Participant already included in another study (exclusivity clause)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Le Mans

Le Mans, 72 000, France

Location

MeSH Terms

Conditions

HydrarthrosisArthritis, InfectiousArthritis

Interventions

Arthrocentesis

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesInfections

Intervention Hierarchy (Ancestors)

ParacentesisSpecimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesTherapeuticsSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Emmanuelle Dernis, MD

    Centre Hospitalier du Mans, Rheumatology Department

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 6, 2019

First Posted

June 10, 2019

Study Start

February 15, 2020

Primary Completion

March 1, 2022

Study Completion

March 1, 2022

Last Updated

March 9, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations